Atria Wealth Solutions Inc. Has $485,000 Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Atria Wealth Solutions Inc. reduced its stake in HCA Healthcare by 58.7% during the second quarter, owning 1,265 shares valued at $485,000.
• HCA Healthcare's recent earnings report showed $6.84 earnings per share, surpassing analysts' expectations of $6.20, with revenue of $18.61 billion.
• The company declared a quarterly dividend of $0.72 per share, representing an annualized yield of 0.7%, and has set FY 2025 guidance at 25.500-27.000 EPS.

Atria Wealth Solutions Inc. trimmed its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 58.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,265 shares of the company's stock after selling 1,795 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in HCA Healthcare were worth $485,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Nuveen LLC purchased a new stake in shares of HCA Healthcare in the first quarter worth approximately $569,217,000. Pacer Advisors Inc. lifted its position in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP purchased a new stake in shares of HCA Healthcare in the first quarter worth approximately $164,835,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Trading Up 1.4%

Shares of HCA stock opened at $425.50 on Monday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01. The firm's fifty day simple moving average is $410.05 and its 200 day simple moving average is $378.63. The firm has a market capitalization of $99.56 billion, a P/E ratio of 17.89, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's payout ratio is currently 12.11%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HCA. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. Morgan Stanley cut their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Weiss Ratings reissued a "buy (b-)" rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. UBS Group lifted their price target on shares of HCA Healthcare from $438.00 to $495.00 and gave the company a "buy" rating in a research report on Tuesday, October 14th. Finally, JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $437.19.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.